Account
Inquiry
Tirzepatide is a novel dual agonist targeting both GLP-1 and gastric inhibitory polypeptide (GIP) receptors, developed for research applications in metabolic disorders. This pharmaceutical grade compound demonstrates high purity (99% by HPLC) and consistent quality for research purposes.
As a research compound, Tirzepatide shows potential in studies related to type 2 diabetes management and metabolic regulation. The molecule functions similarly to natural incretin hormones, stimulating insulin secretion while potentially offering additional metabolic benefits.
Our facility offers Tirzepatide in various packaging configurations to meet diverse research requirements. The product is handled under strict quality control measures to ensure batch-to-batch consistency and stability.
For researchers seeking competitive tirzepatide UK price options, we provide wholesale quantities with flexible packaging solutions. The product is supplied exclusively for laboratory research applications.
